1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  05/27 11:35:29 am EDT
3.614 EUR   +4.75%
05/26European ADRs Move Higher in Thursday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/24Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Trading Slightly Higher Thursday

12/30/2021 | 11:05am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ABB LTD 1.94% 29.36 Delayed Quote.-15.87%
ADAPTIMMUNE THERAPEUTICS PLC 4.11% 1.52 Delayed Quote.-59.47%
AKARI THERAPEUTICS, PLC -2.46% 1.19 Delayed Quote.-20.67%
ARCELORMITTAL 3.24% 30.445 Real-time Quote.8.17%
AUTOLUS THERAPEUTICS PLC 1.55% 2.62 Delayed Quote.-49.52%
BIONTECH SE 5.57% 166.96 Delayed Quote.-35.24%
CELLECTIS S.A. 4.75% 3.614 Real-time Quote.-51.42%
DIAGEO PLC 0.14% 3643.5 Delayed Quote.-9.73%
EDAP TMS S.A. -0.56% 7.1 Delayed Quote.18.53%
MATERIALISE NV 4.98% 15.39 Delayed Quote.-35.53%
MEREO BIOPHARMA GROUP PLC 8.77% 0.521 Delayed Quote.-67.44%
NATIONAL GRID PLC -1.90% 1164 Delayed Quote.9.83%
NUCANA PLC -3.39% 0.599 Delayed Quote.-74.83%
OPERA LIMITED 0.76% 5.28 Delayed Quote.-25.21%
TELEFÓNICA, S.A. -0.10% 4.947 Delayed Quote.28.43%
VIA OPTRONICS AG -2.19% 2.45 Delayed Quote.-66.67%
All news about CELLECTIS S.A.
05/26European ADRs Move Higher in Thursday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/24Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
05/24Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23CELLECTIS S A : ' Annual Shareholders' General Meeting to be Held on June 28, 2022 - Form ..
PU
05/23Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
GL
05/23Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23CELLECTIS S A : Consolidated Financial Statements - Form 6-K
PU
05/20CALYXT, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand..
AQ
05/20European ADRs Move Sharply Higher in Friday Trading
MT
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2022 66,3 M 71,1 M 71,1 M
Net income 2022 -83,2 M -89,1 M -89,1 M
Net cash 2022 41,5 M 44,4 M 44,4 M
P/E ratio 2022 -1,63x
Yield 2022 -
Capitalization 164 M 176 M 176 M
EV / Sales 2022 1,85x
EV / Sales 2023 -1,20x
Nbr of Employees 297
Free-Float 84,3%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 3,61 €
Average target price 16,00 €
Spread / Average Target 343%
EPS Revisions
Managers and Directors
André Choulika Chief Executive Officer & Director
Bing C. Wang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Carrie Brownstein Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-51.42%176
MODERNA, INC.-41.86%58 733
LONZA GROUP AG-24.79%44 437
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026
ICON PUBLIC LIMITED COMPANY-26.61%18 478